Healthcare Global Enterprises Ltd

Health.Global Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Healthcare Global Enterprises Ltd

₹ 368 -0.54%
19 Apr 12:44 p.m.
hcgoncology.com BSE: 539787 NSE : HCG
About

Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.[1]

Key Points

Service Offering
The Company is a provider of specialty healthcare focused on cancer and fertility. Under the “HCG” brand, it operates the largest cancer care network in India in terms of the total number of private cancer treatment centers licensed by the AERB. It also provides fertility treatment under our “Milann” brand. [1]

Website BSE NSE
  • Market Cap ₹ 5,125 Cr.
  • Current Price ₹ 368
  • High / Low ₹ 401 / 257
  • Stock P/E 218
  • Book Value ₹ 61.6
  • Dividend Yield 0.00 %
  • ROCE 8.39 %
  • ROE 2.10 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 5.94 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Company has a low return on equity of -4.73% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
274.01 298.05 323.14 351.96 358.06 364.63 408.05 420.00 424.68 441.71 460.68 486.94 469.87
236.17 258.69 271.91 292.22 296.21 301.48 335.89 345.31 349.18 365.40 386.37 402.32 391.26
Operating Profit 37.84 39.36 51.23 59.74 61.85 63.15 72.16 74.69 75.50 76.31 74.31 84.62 78.61
OPM % 13.81% 13.21% 15.85% 16.97% 17.27% 17.32% 17.68% 17.78% 17.78% 17.28% 16.13% 17.38% 16.73%
-2.69 -79.42 4.01 143.42 -42.59 3.01 2.91 1.97 3.65 4.65 2.77 3.40 6.07
Interest 28.71 25.91 26.38 23.23 24.02 24.14 24.98 25.81 27.08 25.63 25.55 26.89 29.46
Depreciation 41.83 38.38 37.78 38.02 41.38 41.10 39.67 40.83 40.77 42.20 41.01 43.21 44.16
Profit before tax -35.39 -104.35 -8.92 141.91 -46.14 0.92 10.42 10.02 11.30 13.13 10.52 17.92 11.06
Tax % 1.86% -9.02% -40.36% 30.24% -7.93% -144.57% 76.20% 47.21% 62.83% 56.97% 65.30% 39.84% 68.99%
-34.73 -113.76 -12.52 98.99 -49.80 2.25 2.48 5.29 4.20 5.65 3.65 10.78 3.43
EPS in Rs -2.33 -8.15 -0.76 8.22 -3.29 0.43 0.44 0.53 0.54 0.60 0.55 0.97 0.41
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
267 338 451 519 584 700 829 976 1,092 1,009 1,395 1,691 1,859
225 292 413 443 499 595 713 864 936 887 1,161 1,394 1,545
Operating Profit 41 47 38 76 85 105 116 112 157 122 234 297 314
OPM % 15% 14% 9% 15% 15% 15% 14% 11% 14% 12% 17% 18% 17%
4 2 3 0 -2 10 25 10 10 -72 110 15 17
Interest 24 29 32 34 38 23 42 70 138 119 98 104 108
Depreciation 24 30 36 39 44 57 71 85 148 159 158 163 171
Profit before tax -3 -10 -27 3 0 35 27 -33 -119 -229 88 45 53
Tax % -8% -7% -20% -56% -730% 34% 38% 7% -5% 3% 56% 61%
-3 -11 -32 5 2 23 17 -31 -125 -221 39 18 24
EPS in Rs -0.56 -1.54 -5.21 0.12 -0.17 2.59 2.36 -2.82 -12.03 -15.43 3.87 2.11 2.53
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 17%
5 Years: 15%
3 Years: 16%
TTM: 15%
Compounded Profit Growth
10 Years: 14%
5 Years: 10%
3 Years: 29%
TTM: 65%
Stock Price CAGR
10 Years: %
5 Years: 13%
3 Years: 30%
1 Year: 41%
Return on Equity
10 Years: -5%
5 Years: -8%
3 Years: -5%
Last Year: 2%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 59 67 68 70 85 86 87 88 89 125 139 139 139
Reserves 152 217 196 210 341 347 428 389 293 528 731 721 719
217 308 292 349 324 420 464 658 1,347 977 915 901 980
77 116 133 147 294 372 461 515 518 401 433 549 581
Total Liabilities 505 708 688 776 1,043 1,225 1,440 1,650 2,246 2,031 2,218 2,311 2,419
392 508 512 528 583 685 828 970 1,646 1,382 1,547 1,553 1,626
CWIP 0 0 11 42 121 148 174 153 46 30 22 18 23
Investments 0 61 2 0 64 11 53 49 34 26 9 10 10
112 139 164 205 275 381 385 478 520 593 641 730 760
Total Assets 505 708 688 776 1,043 1,225 1,440 1,650 2,246 2,031 2,218 2,311 2,419

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
19 31 51 60 73 91 98 98 130 121 220 252
-46 -178 -12 -79 -204 -210 -283 -238 -101 -171 125 -133
38 140 -27 22 216 89 161 84 -58 112 -155 -140
Net Cash Flow 11 -7 13 2 85 -29 -24 -56 -30 62 190 -22

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 59 65 43 45 43 54 57 59 62 67 57 65
Inventory Days 32 35 33 36 32 40 46 45 35 32 31 33
Days Payable 163 186 193 208 264 272 274 303 234 221 199 214
Cash Conversion Cycle -73 -86 -117 -127 -188 -178 -171 -200 -136 -121 -112 -116
Working Capital Days 16 -4 -20 -44 -72 -90 -73 -92 -70 33 -21 -22
ROCE % 6% 4% 1% 7% 6% 7% 6% 3% 1% -1% 5% 8%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
68.41% 68.40% 71.44% 71.43% 71.42% 71.39% 71.39% 71.37% 71.35% 71.30% 71.29% 71.28%
6.42% 7.24% 7.03% 6.99% 7.22% 7.27% 7.18% 6.37% 6.47% 6.29% 6.37% 6.74%
9.69% 8.16% 6.59% 5.86% 4.55% 4.02% 4.41% 5.53% 6.58% 7.94% 8.46% 8.52%
15.48% 16.19% 14.94% 15.73% 16.81% 17.32% 17.04% 16.71% 15.59% 14.49% 13.89% 13.45%
No. of Shareholders 15,06520,57322,36223,66323,01824,67228,70728,85825,93127,32727,28927,195

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls